IUD Clinical Trial - Barriers of Immediate Postpartum Intrauterine Device

Status Not yet recruiting

Clinical Trial Summary

increase immediate postpartum intrauterine device uptake and support family planning programs to overcome barriers and increase contraception prevalence rate in Egypt determine client related barriers of immediate postpartum intrauterine device uptake in Assiut Hospitals (Demand side) identify provider related barriers of immediate postpartum intrauterine device uptake in Assiut Hospitals (Supply side) describe method related barriers perceived by women

Clinical Trial Description

Population increase in Egypt is a major problem with the fertility rate 3.5 children per woman the postpartum period starts after the birth of the placenta and lasts for 6-8weeks after delivery Women resume sexual activity 1 to 2 months after delivery, with 45-day average till return of ovulation. women returning for intrauterine device insertion 6-8 weeks are at risk of unintended pregnancy Insertion of postpartum intrauterine device is immediate or interval. immediate Postpartum intrauterine device inserted from the placental delivery time (within 10 minutes), or within first 48 hours, it can be done after vaginal or caesarean. Postpartum intrauterine device can improve mothers' health by reducing difficulties from closely spaced pregnancies Immediate postpartum intrauterine device uptake is low in most developing countries and Egypt due to several barriers - Health facility: provider knowledge, attitude, lack of training, counseling, privacy, shortage of supply of intrauterine device,poor quality of service, bad experience with the facility - Community: as Sociodemographic (desire more children), cultural norms, husband opposition, and religious beliefs , fear of side effects., Cognitive (didn't hear about family planning in past 6 months), reproductive (long interval between intercourse), medical (requiring checkups) physical (distance of clinic) The rational is postpartum women are motivated to avoid pregnancy, 90% of women deliver in hospitals, they are in facilities with skilled physicians who can offer contraception. Immediate postpartum intrauterine device is cost-effective and efficient Assiut implemented a program training physicians on immediate Postpartum intrauterine device insertion in 2021. This study will support the newly implemented program to overcome barriers from demand and supply sides and direct the program to future activity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05471362
Study type	Observational
Source	Assiut University
Contact	Mireille Hanna, Bachelor's
Phone	+201110777565
Email	miray.maged222@med.aun.edu.eg
Status	Not yet recruiting
Phase
Start date	December 1, 2022
Completion date	February 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03868137` - Multi-dose Ibuprofen Prophylaxis for IUD-insertion	N/A
Completed	`NCT04539899` - Evaluation of the Influence of the Virtual Reality Helmet on Pain During IUD Insertion	N/A
Recruiting	`NCT06023849` - Trans Caesarean Intra Uterine Contraceptive Device Insertion Versus Conventional Postpartum 6 Weeks Insertion	N/A
Completed	`NCT04932382` - Misoprostol Prior to Intrauterine Device Insertion	N/A
Active, not recruiting	`NCT04927741` - Essential Oils Following IUD Insertion	N/A
Completed	`NCT05383924` - Intrauterine Contraceptive Device Insertion During Cesarean Section (CS) Versus Delayed Insertion	N/A
Completed	`NCT04389021` - Virtual Reality Simulation for Intrauterine Device Insertion: A Randomized Clinical Trial	N/A
Completed	`NCT05187078` - Allis Clamp Versus Single-tooth Tenaculum	N/A
Recruiting	`NCT05339555` - IUD Self-Removal Study	N/A
Completed	`NCT04379102` - The Role Of Local Anesthetics in the Management of Adverse Effects Associated With Intrauterine Device Application
Recruiting	`NCT05875571` - Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement	Phase 4
Active, not recruiting	`NCT02076217` - Quick Start of Highly Effective Contraception
Recruiting	`NCT05700812` - IUD Placement Without Sounding	N/A
Recruiting	`NCT05252117` - Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.	Phase 4
Not yet recruiting	`NCT04630548` - Safety and Efficacy of Immediate Post Placental IUD Insertion in Patients Undergoing Cesarean Delivery	N/A
Not yet recruiting	`NCT05283798` - Insertion of Copper T380 Versus Multiload IUD Post Partum	N/A
Not yet recruiting	`NCT06240260` - TENS Unit for Analgesia During IUD Insertion	N/A
Completed	`NCT06042556` - IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Barriers of Immediate Postpartum Intrauterine Device Uptake

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms